Research Article
Immunologic and Clinical Failure of Antiretroviral Therapy in People Living with Human Immunodeficiency Virus within Two Years of Treatment
Table 1
Demographic and clinical characteristics of HIV patients in Ayder Comprehensive Specialized Hospital, 2017 (
).
| | Variable | Frequency (%) |
| | Age (in year) | 16-29 | 294 (38.2) | | 30-44 | 390 (50.6) | | ≥44 | 86 (11.2) |
| | BMI (in kg/m2) | <18 | 286 (37.1) | | 18-24.9 | 429 (55.7) | | 25-34 | 55 (7.1) |
| | Sex | Female | 442 (57.4) | | Male | 328 (42.6) |
| | Residence | Rural | 190 (24.7) | | Urban | 580 (75.3) |
| | Why eligible | Clinical only | 45 (5.8) | | CD4 count | 547 (71.0) | | Others | 178 (23.2) |
| | Baseline functional status | Ambulatory | 203 (26.4) | | Working | 487 (63.2) | | Bedridden | 80 (10.4) |
| | Baseline WHO stage | T1 | 113 (14.7) | | T2 | 97 (12.6) | | T3 | 410 (53.2) | | T4 | 150 (19.5) |
| | Baseline TB screen | Positive | 167 (21.7) | | Negative | 603 (78.3) |
| | Baseline ARV regimen | TDF+3TC+EFV | 312 (40.5) | | AZT+3TC+NVP | 235 (30.5) | | D4T+3TC+NVP | 100 (13.0) | | TDF+3TC+NVP | 79 (10.3) | | D4T+3TC+EFV | 26 (3.4) | | AZT+3TC+EFV | 18 (2.3) |
|
|
Others: TB, HBV, and pregnancy.
|
